Patients with relapsed or refractory lymphomas may benefit from CAR-NK cell immunotherapy and Have fewer adverse events.
Caitlyn Tompkins
Advertisement
Articles by Caitlyn Tompkins
Advertisement
Latest Updated Articles
CAR-NK Cell Immunotherapy Shows PromisePublished: August 15th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
2
Amivantamab Shows 45% Response Rate in Pretreated Head and Neck Cancer: OrigAMI-4 Findings
3
FDA Approves Gazyva for Active Lupus Nephritis
4
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer
5
